D
Delcath Systems, Inc. (DCTH)
NCM – Real Time Price. Currency in USD
11.34
+0.28 (2.53%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
11.34
+0.28 (2.53%)
At close: May 12, 2026, 4:00 PM EDT
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company’s lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. The company also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. The company was founded in 1988 and is headquartered in Queensbury, New York.
| Name | Position |
|---|---|
| Dr. Johnny John M.D. | Senior Vice President of Clinical Operations & Medical Affairs |
| Dr. Martha S. Rook Ph.D. | Chief Operating Officer |
| Dr. Michael Brunner M.D. | Senior Vice President of Interventional Oncology |
| Dr. Vojislav Vukovic M.D., M.Sc., Ph.D. | Chief Medical Officer |
| Mr. David Hoffman J.D. | General Counsel, Corporate Secretary & Chief Compliance Officer |
| Mr. Gerard J. Michel MBA, MS | CEO & Director |
| Mr. Kevin Muir | Chief Commercial Officer |
| Ms. Sandra Pennell CPA | Chief Financial Officer |
| Date | Type | Document |
|---|---|---|
| 2026-05-07 | 8-K | dcth-20260507.htm |
| 2026-05-07 | 10-Q | dcth-20260331.htm |
| 2026-04-02 | DEFA14A | delcathsystemsincdefa14a20.htm |
| 2026-04-02 | DEF 14A | dcth-20260401.htm |
| 2026-03-03 | 8-K | d16781d8k.htm |
| 2026-02-26 | 10-K | dcth-20251231.htm |
| 2026-01-12 | 8-K | d52022d8k.htm |
| 2025-11-20 | 8-K | d68033d8k.htm |
| 2025-11-04 | 10-Q | dcth-20250930.htm |
| 2025-10-20 | 8-K | d51469d8k.htm |